Faber J, Heaf J, Kirkegaard C, Lumholtz I B, Siersbaek-Nielsen K, Kølendorf K, Friis T
J Clin Endocrinol Metab. 1983 Feb;56(2):211-7. doi: 10.1210/jcem-56-2-211.
The present study evaluates the sequential extra-thyroidal monodeiodination of thyroid hormones through tri-, di-, and monoiodothyronines in chronic renal failure (CRF) in man. Simultaneous turnover studies of T4, T3, rT3, 3,5-diiodothyronine (3,5-T2), 3,3'-T2, 3',5'-T2, 3'5'-T2, and 3'-monoiodothyronine (3--T1) were conducted in six patients with CRF (creatinine clearance, 9-18 ml/min) using the single-injection, noncompartmental approach. Serum levels of T4, T3, and 3,5-T2 were reduced to two thirds of control levels (P less than 0.05), whereas serum rT3 and 3,3'-T2 levels were reduced to a minor degree. Serum 3'-5'-T1 was doubled (p less than 0.05). The MCRs of T4, rT3, and 3',5'-T2 were enhanced to 168%, 127%, and 187% of normal (P less than 0.05), respectively, whereas those of T3, 3,5-T2, 3,3'-T2, and 3'-T1 were unaffected. The mean production rates (PRs) of the iodothyronines in CRF were as follows (CRF vs. control values, expressed as nanomoles per day/70 kg): T4, 119 vs. 125; T3, 26 vs. 44 (P less than 0.01); rT3, 49 vs, 48; 3,5-T2, 3.5 vs. 7.2 (P less than 0.001); 3,3'-T2, 25 vs. 35 (P less than 0.01); 3',5'-T2, 25 vs. 14 (P less than 0.01); and 3'-T1, 39 vs. 30. Previous studies have demonstrated reduced phenolic ring (5'-) deiodination of T4 in CRF, which is supported by the present finding of unaltered PR of T4 and reduced PR of T3. In contrast the 5'-deiodination of T3 leading to the formation of 3,5-T2 was found unaffected by CRF, since the conversion rate (CR) of T3 to 3,5-T2 (PR 3,5-T2/PR T3) was unaltered (16% vs. 15% in controls). The tyrosylic ring (5-) deiodination of T4 to rT3 was unaffected in patients with CRF, the CR being 42% vs. 40% in controls, in contrast to an enhanced CR of rT3 to 3',5'-T2 (53% vs. 29%, P less than 0.01), which also is a 5-deiodination step. In conclusion, our data show that CRF profoundly changes the kinetics of all iodothyronines studied. Furthermore, our data are compatible with the existence of more than one 5'-deiodinase as well as more than one 5-deiodinase in man.
本研究评估了慢性肾衰竭(CRF)患者体内甲状腺激素通过三碘甲状腺原氨酸、二碘甲状腺原氨酸和一碘甲状腺原氨酸进行的甲状腺外顺序单碘化过程。采用单次注射、非房室模型方法,对6例CRF患者(肌酐清除率为9 - 18 ml/min)进行了T4、T3、反式T3、3,5 - 二碘甲状腺原氨酸(3,5 - T2)、3,3'-二碘甲状腺原氨酸(3,3'-T2)、3',5'-二碘甲状腺原氨酸(3',5'-T2)和3'-一碘甲状腺原氨酸(3'-T1)的同时转换研究。T4、T3和3,5 - T2的血清水平降至对照水平的三分之二(P < 0.05),而血清反式T3和3,3'-T2水平仅轻度降低。血清3'-5'-T1水平翻倍(P < 0.05)。T4、反式T3和3',5'-T2的代谢清除率(MCR)分别提高至正常水平的168%、127%和187%(P < 0.05),而T3、3,5 - T2、3,3'-T2和3'-T1的MCR未受影响。CRF患者中碘甲状腺原氨酸的平均生成率(PR)如下(CRF与对照值,以纳摩尔/天/70 kg表示):T4,119对125;T3,26对44(P < 0.01);反式T3,49对48;3,5 - T2,3.5对7.2(P < 0.001);3,3'-T2,25对35(P < 0.01);3',5'-T2,25对14(P < 0.01);3'-T1,39对30。既往研究表明CRF患者T4的酚环(5'-)脱碘减少,本研究中T4的PR未改变而T3的PR降低支持了这一发现。相反,导致3,5 - T2形成的T3的5'-脱碘未受CRF影响,因为T3向3,5 - T2的转化率(CR)未改变(对照组为16%,CRF组为15%)。CRF患者中T4向反式T3的酪氨酰环(5 -)脱碘未受影响,CR为42%,对照组为40%,相反,反式T3向3',5'-T2的CR升高(53%对29%,P < 0.01),这也是一个5 - 脱碘步骤。总之,我们的数据表明CRF深刻改变了所研究的所有碘甲状腺原氨酸的动力学。此外,我们的数据与人存在不止一种5'-脱碘酶以及不止一种5 - 脱碘酶相一致。